3D Knee Kinematics Assessment for Understanding Knee Movement
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand knee movement during everyday activities using a new 3D imaging system. The researchers seek to determine if this method provides a clearer picture of knee movement, potentially aiding future injury treatments. Participants will undergo a minimally invasive procedure under local anesthesia to measure knee movements through 3D knee kinematic assessment. The study seeks individuals requiring knee arthroscopy for a medial meniscal tear.
As an unphased study, this trial offers participants the chance to contribute to innovative research that could enhance knee injury treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this 3D knee kinematic assessment is safe?
Research has shown that using a 3D knee movement assessment system with local anesthesia is generally safe. In past studies, similar methods have shown promise without causing serious side effects. This approach is minimally invasive, avoiding large cuts or major surgery, and instead uses advanced imaging to study knee movement.
While specific data on negative effects is limited, local anesthesia is usually well-tolerated. It numbs a small area and is often used in minor medical procedures. Since this trial focuses on studying knee movements rather than testing new drugs, the risk of severe side effects is lower.
In summary, current research indicates that this procedure is safe and manageable for participants, with a low risk of major complications.12345Why are researchers excited about this trial?
Researchers are excited about the 3D knee kinematic assessment because it offers a new way to understand knee movement in detail. Unlike traditional methods that might rely on external observation or basic imaging, this technique uses advanced 3D technology to capture precise motion data. By performing the assessment under local anesthesia, it allows for a more accurate analysis of knee function without the interference of pain or discomfort. This could lead to better diagnosis and personalized treatment plans for knee-related issues, ultimately improving patient outcomes.
What evidence suggests that this 3D knee kinematic assessment is effective for understanding knee movement?
Research has shown that 3D knee movement assessments provide detailed insights into knee motion. In this trial, participants will undergo a 3D knee kinematic assessment under local anesthesia. These assessments effectively diagnose knee osteoarthritis (KOA) by analyzing gait, aiding in treatment planning. Studies highlight the accuracy and reliability of 3D systems in capturing knee movements. This technology offers real-time information about knee alignment, crucial for understanding knee health during various activities. Overall, evidence supports the potential of 3D knee movement assessments to enhance the understanding and management of knee conditions.46789
Who Is on the Research Team?
Frédéric Lavoie, MD MSc FRCSC
Principal Investigator
CHUM
Are You a Good Fit for This Trial?
This trial is for patients who are scheduled for knee arthroscopy due to a medial meniscal tear and can move their knee well enough to do certain tasks. People with active infections, severe knee swelling, stiff knees that can't bend fully, or those who limp heavily cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
3D Kinematic Assessment
3D knee kinematic assessment under local anesthesia using a novel minimally invasive measuring system
Follow-up
Participants are monitored for safety and effectiveness after the kinematic assessment
What Are the Treatments Tested in This Trial?
Interventions
- 3D knee kinematic assessment under local anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor
Eiffel Medtech
Industry Sponsor